AIDS vaccine trials may have added risk

Mar 21, 2008

Two field tests of an AIDS vaccine not only failed to protect people from the virus but may have put them at greater risk, U.S. researchers said.

The results of the worldwide trials prompted scientific inquiry as researchers try to assess what happened and whether they should known the outcome, The Washington Post reported Friday.

Both field tests were halted in September and seven other trials of similarly designed AIDS vaccines have been stopped or postponed indefinitely.

"This is on the same level of catastrophe as the (NASA space shuttle) Challenger disaster," said Robert Gallo, co-discoverer of the human immunodeficiency virus, the virus that causes AIDS, and head of the Institute for Human Virology in Baltimore.

The STEP and Phambili studies used the same vaccine and were stopped when it became evident the studies were futile and possibly harmful, the Post reported.

One hypothesis for what went wrong is the vaccine somehow prepared the immune system to be more susceptible to HIV infection, a scenario that wasn't foreseen or suggested by previous studies, the Post said.

The National Institutes of Health in Bethesda, Md, which funded the trials, will meet week to reassess its AIDS vaccine program.

Copyright 2008 by United Press International

Explore further: Preventing one case of HIV saves over $225K, study shows

add to favorites email to friend print save as pdf

Related Stories

Spanish doctors unveil promising AIDS vaccine

Feb 01, 2011

Spanish researchers announced Tuesday they have developed an AIDS vaccine which cuts the viral load by a significant amount in most patients although they cautioned it is still not enough as a treatment.

Recommended for you

Preventing one case of HIV saves over $225K, study shows

Feb 27, 2015

How much money would be saved if one high-risk person was prevented from contracting HIV in the United States? A new study led by a researcher at Weill Cornell Medical College and published online Feb. 24 in Medical Care, answer ...

Research captures transient details of HIV genome packaging

Feb 27, 2015

Once HIV-1 has hijacked a host cell to make copies of its own RNA genome and viral proteins, it must assemble these components into new virus particles. The orchestration of this intricate assembly process falls to a viral ...

Could an HIV drug beat strep throat, flesh-eating bacteria?

Feb 25, 2015

With antibiotic resistance on the rise, scientists are looking for innovative ways to combat bacterial infections. The pathogen that causes conditions from strep throat to flesh-eating disease is among them, but scientists ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

herpesdate
not rated yet Mar 21, 2008
good info. HIV People at www.HerpesFinder.com may like it

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.